首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1489160

全球大麻药品市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Cannabis Pharmaceuticals Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年05月01日 | 出版商:

Value Market Research | 英文 121 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球大麻药品市场需求预计将从 2023 年的 39.7 亿美元达到近 1,916.8 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 53.86%。

大麻药品是从大麻植物中提取的医疗产品，旨在治疗各种健康状况。这些药物含有大麻素（例如 THC 和 CBD）等活性化合物，并且有多种形式，包括油剂、胶囊、喷雾剂和局部应用。它们用于治疗慢性疼痛、癫痫、多发性硬化症和化疗引起的噁心等症状。这些都是根据严格的监管标准开发的，以确保一致性、安全性和有效性。随着研究不断验证其治疗功效以及合法化在许多地区的扩大，它们的使用正在不断增长。

市场动态

各国对医用大麻的日益接受和合法化主要是在市场成长期间。随着越来越多的地区认识到大麻的治疗功效，对医药级大麻产品的需求不断增加。此外，越来越多的研究和临床试验证明大麻在解决癫痫、慢性疼痛和多发性硬化症等多种医疗状况方面的功效，正在推动市场成长。标准化大麻配方和剂量的开发确保了一致性和安全性，使这些产品对医疗保健提供者和患者更具吸引力。此外，人口老化更容易出现可以用大麻药物治疗的疾病，这极大地促进了市场需求。

萃取和配方技术的进步也推动了市场的发展，使高品质、纯净和有效的大麻药品的生产成为可能。製药公司对基于大麻的新疗法的研究和开发的投资不断增加，预计将产生创新产品并扩大现有药物的适应症。此外，医学界和患者对大麻药物益处的认识和接受程度不断提高，进一步推动了市场成长。然而，严格的法规和社会耻辱可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对大麻製药全球市场的每个细分市场进行了包容性评估。大麻製药业的成长和趋势为本研究提供了整体方法。

市场区隔

大麻製药市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

萨蒂克斯
Epidiolex
其他品牌

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲大麻製药市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。大麻製药市场的主要参与者包括 Jazz Pharmaceuticals Inc.、AbbVie Inc.、Insys Therapeutics Inc.、Bausch Health Companies Inc.。伙伴关係、财务概览、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 7 章：大麻製药公司的竞争格局

大麻药品市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 8 章：公司简介

顶级公司市占率分析
市场集中度
Jazz Pharmaceuticals Inc.

公司简介
公司收入
产品
最近的发展

AbbVie Inc.

公司简介
公司收入
产品
最近的发展

Insys Therapeutics Inc.

公司简介
公司收入
产品
最近的发展

Bausch Health Companies Inc

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114737

The global demand for Cannabis Pharmaceuticals Market is presumed to reach the market size of nearly USD 191.68 Billion by 2032 from USD 3.97 Billion in 2023 with a CAGR of 53.86% under the study period 2024-2032.

Cannabis pharmaceuticals are medical products derived from the cannabis plant, formulated to treat various health conditions. These pharmaceuticals contain active compounds such as cannabinoids (e.g., THC and CBD) and are available in multiple forms, including oils, capsules, sprays, and topical applications. They are used to manage symptoms of chronic pain, epilepsy, multiple sclerosis, and chemotherapy-induced nausea, among others. These are developed under strict regulatory standards to ensure consistency, safety, and efficacy. Their use is growing as research continues to validate their therapeutic benefits and as legalization expands in many regions.

MARKET DYNAMICS

The growing acceptance & legalization of cannabis for medical use in various countries is primarily during market growth. As more regions recognize the therapeutic benefits of cannabis, the demand for pharmaceutical-grade cannabis products rises. Additionally, growing research and clinical trials demonstrating the efficacy of cannabis in addressing an extensive range of medical conditions, such as epilepsy, chronic pain, and multiple sclerosis, are boosting market growth. The development of standardized cannabis formulations and dosages ensures consistency and safety, making these products more appealing to both healthcare providers and patients. Furthermore, the aging population, which is more prone to conditions that can be treated with cannabis pharmaceuticals, significantly contributes to market demand.

Advances in extraction and formulation technologies are also driving the market, enabling the production of high-quality, pure, and effective cannabis pharmaceuticals. The increasing investment by pharmaceutical companies in the research and development of new cannabis-based therapies is expected to result in innovative products and expanded indications for existing medications. Additionally, growing awareness and acceptance among the medical community and patients regarding the benefits of cannabis pharmaceuticals further drive market growth. However, stringent regulations and societal stigma may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cannabis Pharmaceuticals. The growth and trends of Cannabis Pharmaceuticals industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cannabis Pharmaceuticals market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Sativex
Epidiolex
Other Brands

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cannabis Pharmaceuticals market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cannabis Pharmaceuticals market include Jazz Pharmaceuticals Inc., AbbVie Inc., Insys Therapeutics Inc., Bausch Health Companies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CANNABIS PHARMACEUTICALS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANNABIS PHARMACEUTICALS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Sativex Historic and Forecast Sales By Regions
5.4. Epidiolex Historic and Forecast Sales By Regions
5.5. Other Brands Historic and Forecast Sales By Regions

6. GLOBAL CANNABIS PHARMACEUTICALS MARKET ANALYSIS BY GEOGRAPHY

6.1. Regional Outlook
6.2. Introduction
6.3. North America Sales Analysis
- 6.3.1 Overview, Historic and Forecast Data Sales Analysis
- 6.3.2 North America By Segment Sales Analysis
- 6.3.3 North America By Country Sales Analysis
- 6.3.4 United States Sales Analysis
- 6.3.5 Canada Sales Analysis
- 6.3.6 Mexico Sales Analysis
6.4. Europe Sales Analysis
- 6.4.1 Overview, Historic and Forecast Data Sales Analysis
- 6.4.2 Europe By Segment Sales Analysis
- 6.4.3 Europe By Country Sales Analysis
- 6.4.4 United Kingdom Sales Analysis
- 6.4.5 France Sales Analysis
- 6.4.6 Germany Sales Analysis
- 6.4.7 Italy Sales Analysis
- 6.4.8 Russia Sales Analysis
- 6.4.9 Rest Of Europe Sales Analysis
6.5. Asia Pacific Sales Analysis
- 6.5.1 Overview, Historic and Forecast Data Sales Analysis
- 6.5.2 Asia Pacific By Segment Sales Analysis
- 6.5.3 Asia Pacific By Country Sales Analysis
- 6.5.4 China Sales Analysis
- 6.5.5 India Sales Analysis
- 6.5.6 Japan Sales Analysis
- 6.5.7 South Korea Sales Analysis
- 6.5.8 Australia Sales Analysis
- 6.5.9 South East Asia Sales Analysis
- 6.5.10 Rest Of Asia Pacific Sales Analysis
6.6. Latin America Sales Analysis
- 6.6.1 Overview, Historic and Forecast Data Sales Analysis
- 6.6.2 Latin America By Segment Sales Analysis
- 6.6.3 Latin America By Country Sales Analysis
- 6.6.4 Brazil Sales Analysis
- 6.6.5 Argentina Sales Analysis
- 6.6.6 Peru Sales Analysis
- 6.6.7 Chile Sales Analysis
- 6.6.8 Rest of Latin America Sales Analysis
6.7. Middle East & Africa Sales Analysis
- 6.7.1 Overview, Historic and Forecast Data Sales Analysis
- 6.7.2 Middle East & Africa By Segment Sales Analysis
- 6.7.3 Middle East & Africa By Country Sales Analysis
- 6.7.4 Saudi Arabia Sales Analysis
- 6.7.5 UAE Sales Analysis
- 6.7.6 Israel Sales Analysis
- 6.7.7 South Africa Sales Analysis
- 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CANNABIS PHARMACEUTICALS COMPANIES

7.1. Cannabis Pharmaceuticals Market Competition
7.2. Partnership/Collaboration/Agreement
7.3. Merger And Acquisitions
7.4. New Product Launch
7.5. Other Developments

8. COMPANY PROFILES OF CANNABIS PHARMACEUTICALS INDUSTRY

8.1. Top Companies Market Share Analysis
8.2. Market Concentration Rate
8.3. Jazz Pharmaceuticals Inc.
- 8.3.1 Company Overview
- 8.3.2 Company Revenue
- 8.3.3 Products
- 8.3.4 Recent Developments
8.4. AbbVie Inc.
- 8.4.1 Company Overview
- 8.4.2 Company Revenue
- 8.4.3 Products
- 8.4.4 Recent Developments
8.5. Insys Therapeutics Inc.
- 8.5.1 Company Overview
- 8.5.2 Company Revenue
- 8.5.3 Products
- 8.5.4 Recent Developments
8.6. Bausch Health Companies Inc
- 8.6.1 Company Overview
- 8.6.2 Company Revenue
- 8.6.3 Products
- 8.6.4 Recent Developments